EMBC Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-06-30: Revenue $271.70M ; Cost of revenue $118.40M ; Research and development $5.60M ; Selling, general and administrative $78.60M . 2026-03-31: Revenue $221.80M ; Cost of revenue $94.00M ; Research and development $5.40M ; Selling, general and administrative $76.20M . 2025-12-31: Revenue $261.20M ; Cost of revenue $99.50M ; Research and development $4.60M ; Selling, general and administrative $77.60M . 2025-06-30: Revenue $295.50M ; Cost of revenue $98.40M ; Research and development $4.40M ; Selling, general and administrative $84.40M . Product or service Separate filed amounts; connecting flows are not established. Components and totals may overlap.
EMBC revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Manufacturing Facility $5.30M Product And Service Other $15.60M Pen Needles $177.50M Safety $36.70M Syringes $36.60M Revenue $271.70M Cost of revenue $118.40M Gross profit $153.30M Operating expenses $104.60M Operating income $48.70M Research & development $5.60M Selling, general & administrative $78.60M Pre-tax income $27.60M Income tax $6.50M Net income $21.10M
Geography Separate filed amounts; connecting flows are not established. Components and totals may overlap.
EMBC revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Non Us $150.90M US $120.80M Revenue $271.70M Cost of revenue $118.40M Gross profit $153.30M Operating expenses $104.60M Operating income $48.70M Research & development $5.60M Selling, general & administrative $78.60M Pre-tax income $27.60M Income tax $6.50M Net income $21.10M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2026-06-30 $271.70M $118.40M $5.60M $78.60M $104.60M $6.50M $21.10M 2026-03-31 $221.80M $94.00M $5.40M $76.20M $92.80M $13.60M -$4.10M 2025-12-31 $261.20M $99.50M $4.60M $77.60M $78.40M $14.80M $44.10M 2025-06-30 $295.50M $98.40M $4.40M $84.40M $103.10M $26.70M $45.50M 2025-03-31 $259.00M $94.90M $8.00M $79.60M $101.20M $12.30M $23.50M 2024-12-31 $261.90M $104.80M $20.30M $81.10M $128.40M -$700.00K $0.00 2024-06-30 $272.50M $82.40M $20.40M $85.70M $134.20M $12.30M $14.70M 2024-03-31 $287.20M $101.80M $18.40M $92.30M $146.20M -$19.00M $28.90M 2023-12-31 $277.30M $91.40M $20.20M $90.30M $140.40M -$5.80M $20.10M 2023-06-30 $286.10M $96.60M $22.60M $87.60M $138.20M $4.90M $15.20M 2023-03-31 $277.10M $87.30M $22.10M $85.20M $134.20M $10.50M $14.00M 2022-12-31 $275.70M $86.90M $16.90M $72.80M $100.00M $20.90M $35.20M 2022-06-30 $291.10M $88.20M $14.30M $83.80M $105.80M $11.20M $62.40M 2022-03-31 $274.50M $83.30M $18.00M $66.90M $92.30M $14.30M $79.60M 2021-12-31 $289.30M $85.40M $16.70M $62.20M $87.30M $17.80M $98.80M 2021-06-30 $295.00M $92.40M $15.70M $60.50M $78.30M $20.20M $104.70M 2021-03-31 $284.20M $87.90M $14.10M $55.80M $69.90M $20.60M $107.90M 2020-12-31 $285.30M $94.00M $14.00M $53.20M $67.20M $19.80M $105.30M
Revenue and expense 6 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2026-03-31 $483.00M $193.50M $10.00M $153.80M $171.20M $28.40M $40.00M 2025-03-31 $520.90M $199.70M $28.30M $160.70M $229.60M $11.60M $23.50M 2024-03-31 $564.50M $193.20M $38.60M $182.60M $286.60M -$24.80M $49.00M 2023-03-31 $552.80M $174.20M $39.00M $158.00M $234.20M $31.40M $49.20M 2022-03-31 $563.80M $168.70M $34.70M $129.10M $179.60M $32.10M $178.40M 2021-03-31 $569.50M $181.90M $28.10M $109.00M $137.10M $40.40M $213.20M
Revenue and expense 9 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2026-06-30 $754.70M $311.90M $15.60M $232.40M $275.80M $34.90M $61.10M 2025-06-30 $816.40M $298.10M $32.70M $245.10M $332.70M $38.30M $69.00M 2024-06-30 $837.00M $275.60M $59.00M $268.30M $420.80M -$12.50M $63.70M 2023-06-30 $838.90M $270.80M $61.60M $245.60M $372.40M $36.30M $64.40M 2022-06-30 $854.90M $256.90M $49.00M $212.90M $285.40M $43.30M $240.80M 2021-06-30 $864.50M $274.30M $43.80M $169.50M $215.40M $60.60M $317.90M
Revenue and expense 12 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2025-09-30 $1.08B $403.60M $37.30M $332.00M $434.70M $40.90M $95.40M 2024-09-30 $1.12B $387.90M $78.80M $365.10M $568.40M -$34.10M $78.30M 2023-09-30 $1.12B $370.90M $85.20M $341.30M $528.40M $35.30M $70.40M 2022-09-30 $1.13B $354.60M $66.90M $294.80M $465.30M $33.00M $223.60M 2021-09-30 $1.17B $364.90M $63.30M $240.30M $308.40M $80.10M $414.80M 2020-09-30 $1.09B $322.90M $61.40M $214.70M $276.10M $58.20M $427.60M